| Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin (NCT00998686) | Phenomix | 2009-11-01 |
| Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients (NCT00778622) | Bristol-Myers Squibb | 2009-11-01 |
| Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus (NCT01241253) | Arizona State University | 2009-11-01 |
| An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes (NCT01022112) | Tanabe Pharma Corporation | 2009-11-01 |
| A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036) (NCT00989079) | Merck Sharp & Dohme LLC | 2009-10-16 |
| Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes (NCT00976495) | AstraZeneca | 2009-10-01 |
| Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes (NCT01006590) | AstraZeneca | 2009-10-01 |
| Effect of Sitagliptin on Endothelial Progenitor Cells (NCT00968006) | University of Padova | 2009-10-01 |
| 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine (NCT00975286) | Sanofi | 2009-10-01 |
| Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial (NCT00975533) | Chinese University of Hong Kong | 2009-10-01 |
| Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function (NCT00949663) | Washington University School of Medicine | 2009-10-01 |
| Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin (NCT01006603) | AstraZeneca | 2009-10-01 |
| Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease (NCT01038050) | Taipei Veterans General Hospital, Taiwan | 2009-10-01 |
| Peanuts Second Meal Glycemic Response (NCT01413126) | Federal University of Vicosa | 2009-10-01 |
| Vitamin D Receptor Polymorphisms and Efficacy of Vitamin D-Fortified Yogurt Drink in Patients With Type 2 Diabetes (NCT01236846) | Tirang R. Neyestani | 2009-10-01 |
| Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus (NCT00985361) | ProMedica Health System | 2009-10-01 |
| Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes (NCT01003184) | AstraZeneca | 2009-10-01 |
| Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes (NCT00974090) | Tanabe Pharma Corporation | 2009-09-01 |
| Anesthesia With Epinephrine in Diabetes Patients is Safe and Effective (NCT02173067) | University of Sao Paulo General Hospital | 2009-09-01 |
| Monotherapy Study of MP-513 in Patients With Type 2 Diabetes (NCT00998881) | Tanabe Pharma Corporation | 2009-09-01 |
| A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes (NCT00960661) | AstraZeneca | 2009-09-01 |
| Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012) (NCT00972322) | Merck Sharp & Dohme LLC | 2009-08-24 |
| A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199) (NCT01409213) | Merck Sharp & Dohme LLC | 2009-08-01 |
| Latinos Understanding the Need for Adherence (NCT02955238) | San Diego State University | 2009-08-01 |
| Study of LX4211 in Subjects With Type 2 Diabetes Mellitus (NCT00962065) | Lexicon Pharmaceuticals | 2009-08-01 |
| 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years (NCT00976937) | Sanofi | 2009-08-01 |
| Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel) (NCT00728156) | Newcastle-upon-Tyne Hospitals NHS Trust | 2009-08-01 |
| Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients (NCT00972244) | AstraZeneca | 2009-08-01 |
| The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and Lipids (NCT00951912) | Sun Yat-sen University | 2009-08-01 |
| A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide (NCT00964262) | Peptron, Inc. | 2009-08-01 |
| Effectiveness of the Farsi Diabetes Self-management Education (FDSME) Program for People With Type 2 Diabetes (NCT01050803) | Tehran University of Medical Sciences | 2009-08-01 |
| Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment (NCT00958269) | Phenomix | 2009-08-01 |
| Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients (NCT02314637) | Tanabe Pharma Corporation | 2009-08-01 |
| Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus (NCT00975065) | Handok Inc. | 2009-08-01 |
| Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes (NCT00971243) | Tanabe Pharma Corporation | 2009-08-01 |
| Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment" (NCT02068508) | Takeda | 2009-07-30 |
| An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201) (NCT01357135) | Merck Sharp & Dohme LLC | 2009-07-15 |
| A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects (NCT00917267) | AstraZeneca | 2009-07-01 |
| Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus (NCT01786707) | Rodolfo Alejandro | 2009-07-01 |
| Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects (NCT00930865) | AstraZeneca | 2009-07-01 |
| Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus (NCT00935532) | AstraZeneca | 2009-07-01 |
| Personality of Diabetic Patients Will Influence Their Medical compliance-a 5 Years Cohort Follow up With Type D Personality (NCT01151293) | Far Eastern Memorial Hospital | 2009-07-01 |
| Metabolic Activation With Almased for Type 2 Diabetes Patients (NCT01680926) | West German Center of Diabetes and Health | 2009-07-01 |
| Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion (NCT01046994) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2009-07-01 |
| Curcumin for Type 2 Diabetic Patients (NCT01052597) | Srinakharinwirot University | 2009-07-01 |
| Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A) (NCT00899470) | AstraZeneca | 2009-06-01 |
| Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus (NCT00923962) | University Hospital, Gentofte, Copenhagen | 2009-06-01 |
| Effects of Lifestyle Modification on Metabolic Parameters in Type 2 Diabetic Patients (NCT01051089) | Inha University Hospital | 2009-06-01 |
| Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes (NCT01456026) | Profil Institut für Stoffwechselforschung GmbH | 2009-06-01 |
| Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes (NCT00924105) | Cytos Biotechnology AG | 2009-06-01 |
| Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects (NCT00904176) | AstraZeneca | 2009-06-01 |
| Interaction Study SLV337/Simvastatin (NCT00924430) | Solvay Pharmaceuticals | 2009-06-01 |
| Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar) (NCT01172743) | Weill Medical College of Cornell University | 2009-06-01 |
| Opportunistic Screening for Prediabetes and Early Diabetes in Primary Care (NCT00787839) | US Department of Veterans Affairs | 2009-06-01 |
| Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B) (NCT00897390) | AstraZeneca | 2009-06-01 |
| A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179) (NCT00888238) | Merck Sharp & Dohme LLC | 2009-05-12 |
| Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride (NCT00924573) | Sanofi | 2009-05-01 |
| Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus (NCT00913367) | Handok Inc. | 2009-05-01 |
| NOX-E36 First-in-Human (FIH) Study (NCT00976729) | TME Pharma AG | 2009-05-01 |
| A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED) (NCT00902161) | Merck Sharp & Dohme LLC | 2009-05-01 |
| Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure (NCT00766857) | Amsterdam UMC, location VUmc | 2009-05-01 |
| A Diabetes Prevention Study Targeting High Risk Individuals With Education and Ongoing Support (NCT00677937) | University Hospitals, Leicester | 2009-05-01 |
| Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin (NCT00850239) | Phenomix | 2009-05-01 |
| Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device (NCT00889668) | Integrity Applications Ltd. | 2009-05-01 |
| Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus (NCT00885378) | AstraZeneca | 2009-05-01 |
| Study of the Durability of Glycemic Control With Nateglinide (NCT00858013) | Ajou University School of Medicine | 2009-04-24 |
| Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) (NCT00885352) | Merck Sharp & Dohme LLC | 2009-04-15 |
| Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events (NCT00886574) | Hanyang University | 2009-04-01 |
| Relationship Between Body Weight and Glycohemoglobin (NCT00892372) | Saitama Medical University | 2009-04-01 |
| Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study (NCT01817127) | University of California, Davis | 2009-04-01 |
| Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes (NCT00859898) | AstraZeneca | 2009-04-01 |
| Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy? (NCT01536808) | Hospices Civils de Lyon | 2009-04-01 |
| Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes (NCT00831779) | AstraZeneca | 2009-04-01 |
| A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension (NCT00894322) | AstraZeneca | 2009-04-01 |
| A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) (NCT00901979) | Novartis Pharmaceuticals | 2009-04-01 |
| Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (NCT00789750) | Daiichi Sankyo | 2009-04-01 |
| A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) (NCT00868790) | Merck Sharp & Dohme LLC | 2009-03-24 |
| Veterans Inpatient Insulin Study and Transition to Outpatient Therapy (NCT00821795) | Dennis G. Karounos, M.D. | 2009-03-11 |
| The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 Diabetes (NCT01626053) | KRJG Services Inc. | 2009-03-01 |
| Efficacy of Structured Insulin Order (NCT01130558) | Massachusetts General Hospital | 2009-03-01 |
| Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus (NCT00856284) | Takeda | 2009-03-01 |
| Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182) (NCT01065766) | Merck Sharp & Dohme LLC | 2009-03-01 |
| Exercise-induced Blood Glucose Response in Patients With Type 2 Diabetes (NCT03335930) | Tri-Service General Hospital (TSGH) | 2009-03-01 |
| A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin (NCT00870194) | AstraZeneca | 2009-03-01 |
| Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease (NCT00642616) | Mannkind Corporation | 2009-03-01 |
| Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus (NCT00865592) | Phenomix | 2009-03-01 |
| Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects (NCT00842556) | AstraZeneca | 2009-03-01 |
| Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes (NCT00942318) | University Hospital, Toulouse | 2009-03-01 |
| Changing Lifestyles for Better Health (NCT00848757) | Yale University | 2009-03-01 |
| Pilot Study to Assess Adherence to a Novel Eating System in Men and Women With Type 2 Diabetes Mellitus (NCT00907075) | Mondelēz International, Inc. | 2009-03-01 |
| Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study (NCT00874809) | Diabetes Care Center | 2009-03-01 |
| A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5) (NCT00877890) | AstraZeneca | 2009-03-01 |
| Drug to Drug Interaction Study With ASP1941 and Metformin (NCT01302145) | Astellas Pharma Inc | 2009-02-25 |
| MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus (NCT00854035) | Ono Pharmaceutical Co., Ltd. | 2009-02-01 |
| Effect of Fish Oil on Insulin Sensitivity (NCT01241474) | University of Aberdeen | 2009-02-01 |
| Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment" (NCT02003014) | Takeda | 2009-02-01 |
| Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment (NCT02153879) | Institut Investigacio Sanitaria Pere Virgili | 2009-02-01 |
| Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus (NCT00941161) | Laboratorios Silanes S.A. de C.V. | 2009-02-01 |
| Therapeutic Exploratory Study of CWP-0403 (NCT00888719) | JW Pharmaceutical | 2009-02-01 |
| Dance Dance Revolution (DDR) in Type 2 Diabetes (NCT00851019) | Charles Drew University of Medicine and Science | 2009-02-01 |